NASDAQ: VERA Vera Therapeutics, Inc. 8-K

Vera aligns with FDA on accelerated ORIGIN 3 timeline; full approval data expected Q3 2026

Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade VERA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 2, 2026 3:37 PM